BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ma Y, Su X, Li X, Zhi X, Jiang K, Xia J, Li H, Yan C, Zhou L. Combined detection of peripheral blood VEGF and inflammation biomarkers to evaluate the clinical response and prognostic prediction of non-operative ESCC. Sci Rep 2021;11:15305. [PMID: 34315926 DOI: 10.1038/s41598-021-94329-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Xu X, Jing J. Inflammation-related parameter serve as prognostic biomarker in esophageal squamous cell carcinoma. Front Oncol 2022;12:900305. [DOI: 10.3389/fonc.2022.900305] [Reference Citation Analysis]
2 Li X, Su X, Yan C, Ma Y, Li H, Xia J, Li H, Jiang Q, Zhou L, Zou Z. Role of vascular endothelial growth factor in radiotherapy resistance to esophageal squamous cell carcinoma. J Cancer Res Clin Oncol 2022. [PMID: 35767192 DOI: 10.1007/s00432-022-04122-x] [Reference Citation Analysis]
3 Zhou S, Sun X, Jin Z, Yang H, Ye W. The role of autophagy in initiation, progression, TME modification, diagnosis, and treatment of esophageal cancers. Crit Rev Oncol Hematol 2022;:103702. [PMID: 35577254 DOI: 10.1016/j.critrevonc.2022.103702] [Reference Citation Analysis]
4 Adeyemi SA, Choonara YE. In Vitro and In Vivo Evaluation of a Cyclic LyP-1-Modified Nanosystem for Targeted Endostatin Delivery in a KYSE-30 Cell Xenograft Athymic Nude Mice Model. Pharmaceuticals 2022;15:353. [DOI: 10.3390/ph15030353] [Reference Citation Analysis]